ATYPICAL CHRONIC MYELOID LEUKEMIA
Clinical trials for ATYPICAL CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for ATYPICAL CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug boost chemo for hard-to-treat blood cancers?
Disease control OngoingThis phase II trial tested whether adding veliparib (a targeted drug) to standard chemotherapy (topotecan and carboplatin) helps people with advanced myeloproliferative disorders, acute myeloid leukemia, or chronic myelomonocytic leukemia. The study enrolled 25 adults whose cance…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Fitness test could guide safer stem cell transplants for seniors
Disease control OngoingThis study tests whether a geriatric assessment—looking at thinking, mobility, mood, nutrition, and medications—can help doctors choose the right transplant intensity for patients aged 60 and older with myeloid blood cancers. The goal is to reduce deaths from transplant complicat…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Promising blood cancer combo trial pulled before it even started
Disease control TerminatedThis early-stage trial aimed to test a combination of two drugs—ASTX727 (already approved for some blood cancers) and ASTX029 (an experimental ERK inhibitor)—in adults with myelodysplastic syndromes (MDS) or related blood cancers that have a mutation in the RAS pathway. The goal …
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could your phone camera replace blood tests? new study explores
Knowledge-focused OngoingThis study follows 60 people with lower-risk myelodysplastic neoplasms (MDS) who need regular red blood cell transfusions. Over 6 months, participants use a smartphone app to answer weekly quality-of-life questions and take photos of their fingernails or eyelids. Researchers aim …
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC